167 related articles for article (PubMed ID: 35777707)
1. Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.
Groenland SL; van Eerden RAG; Westerdijk K; Meertens M; Koolen SLW; Moes DJAR; de Vries N; Rosing H; Otten H; Vulink AJE; Desar IME; Imholz ALT; Gelderblom H; van Erp NP; Beijnen JH; Mathijssen RHJ; Huitema ADR; Steeghs N;
Ann Oncol; 2022 Oct; 33(10):1071-1082. PubMed ID: 35777707
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.
Groenland SL; van Eerden RAG; Verheijen RB; Koolen SLW; Moes DJAR; Desar IME; Reyners AKL; Gelderblom HJ; van Erp NP; Mathijssen RHJ; Huitema ADR; Steeghs N
Ther Drug Monit; 2019 Oct; 41(5):561-567. PubMed ID: 31568233
[TBL] [Abstract][Full Text] [Related]
3. Precision Dosing of Targeted Therapies Is Ready for Prime Time.
Groenland SL; Verheijen RB; Joerger M; Mathijssen RHJ; Sparreboom A; Beijnen JH; Beumer JH; Steeghs N; Huitema ADR
Clin Cancer Res; 2021 Dec; 27(24):6644-6652. PubMed ID: 34548319
[TBL] [Abstract][Full Text] [Related]
4. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
[TBL] [Abstract][Full Text] [Related]
5. Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programme.
Groenland SL; van Nuland M; Bergman AM; de Feijter JM; Dezentje VO; Rosing H; Beijnen JH; Huitema ADR; Steeghs N;
Eur J Cancer; 2020 May; 130():32-38. PubMed ID: 32172196
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility study.
de Wit D; van Erp NP; den Hartigh J; Wolterbeek R; den Hollander-van Deursen M; Labots M; Guchelaar HJ; Verheul HM; Gelderblom H
Ther Drug Monit; 2015 Jun; 37(3):331-8. PubMed ID: 25271729
[TBL] [Abstract][Full Text] [Related]
7. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Comment on 'Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study' by Dr Steffie L. Groenland et al.
Rubovszky G; Torday L
Ann Oncol; 2023 Jul; 34(7):628-629. PubMed ID: 37100204
[No Abstract] [Full Text] [Related]
10. Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.
Westerdijk K; Desar IME; Steeghs N; van der Graaf WTA; van Erp NP;
Br J Clin Pharmacol; 2020 Feb; 86(2):258-273. PubMed ID: 31782166
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours - Results from daily clinical practice.
IJzerman NS; Groenland SL; Koenen AM; Kerst M; van der Graaf WTA; Rosing H; Beijnen JH; Huitema ADR; Steeghs N
Eur J Cancer; 2020 Sep; 136():140-148. PubMed ID: 32688207
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
13. Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.
McGann PT; Niss O; Dong M; Marahatta A; Howard TA; Mizuno T; Lane A; Kalfa TA; Malik P; Quinn CT; Ware RE; Vinks AA
Am J Hematol; 2019 Aug; 94(8):871-879. PubMed ID: 31106898
[TBL] [Abstract][Full Text] [Related]
14. A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy.
Patel JN; O'Neil BH; Deal AM; Ibrahim JG; Sherrill GB; Olajide OA; Atluri PM; Inzerillo JJ; Chay CH; McLeod HL; Walko CM
Oncologist; 2014 Sep; 19(9):959-65. PubMed ID: 25117066
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of individualized pharmacokinetically-guided dosing of paclitaxel compared with body-surface area dosing in Chinese patients with advanced non-small cell lung cancer.
Zhang J; Zhou F; Qi H; Ni H; Hu Q; Zhou C; Li Y; Baburina I; Courtney J; Salamone SJ
Br J Clin Pharmacol; 2019 Oct; 85(10):2292-2301. PubMed ID: 31077432
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.
Groenland SL; van Nuland M; Verheijen RB; Schellens JHM; Beijnen JH; Huitema ADR; Steeghs N
Clin Pharmacokinet; 2019 Mar; 58(3):299-308. PubMed ID: 29862467
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetically guided dosing has the potential to improve real-world outcomes of pazopanib.
Fukudo M; Tamaki G; Azumi M; Shibata H; Tandai S
Br J Clin Pharmacol; 2021 Apr; 87(4):2132-2139. PubMed ID: 33010046
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.
Guchelaar NAD; van Eerden RAG; Groenland SL; Doorn LV; Desar IME; Eskens FALM; Steeghs N; van Erp NP; Huitema ADR; Mathijssen RHJ; Koolen SLW;
Biomed Pharmacother; 2022 Sep; 153():113393. PubMed ID: 35834987
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetically Guided Dosing of Oral Drugs: True Precision Oncology?
Ornstein MC; Rini BI
Clin Cancer Res; 2016 Dec; 22(23):5626-5628. PubMed ID: 27663599
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.
Davis JM; Ivanova A; Chung Y; Shaw JR; Rao KV; Ptachcinski JR; Sharf AA; Serody JS; Armistead PM; Wood WA; Coghill JM; Jamieson KJ; Vincent BG; Riches ML; Shea TC; Alexander MD
Biol Blood Marrow Transplant; 2019 Feb; 25(2):391-397. PubMed ID: 30244102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
